Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Lisata Therapeutics (LSTA) over the last 11 years, with Q1 2025 value amounting to -$962000.0.

  • Lisata Therapeutics' Tax Provisions fell 2055.14% to -$962000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$962000.0, marking a year-over-year decrease of 2055.14%. This contributed to the annual value of -$798000.0 for FY2024, which is 6575.11% up from last year.
  • Lisata Therapeutics' Tax Provisions amounted to -$962000.0 in Q1 2025, which was down 2055.14% from -$798000.0 recorded in Q1 2024.
  • Lisata Therapeutics' 5-year Tax Provisions high stood at -$798000.0 for Q1 2024, and its period low was -$2.3 million during Q2 2023.
  • Its 3-year average for Tax Provisions is -$1.4 million, with a median of -$962000.0 in 2025.
  • The largest annual percentage gain for Lisata Therapeutics' Tax Provisions in the last 5 years was 2055.14% (2025), contrasted with its biggest fall of 2055.14% (2025).
  • Quarter analysis of 3 years shows Lisata Therapeutics' Tax Provisions stood at -$2.3 million in 2023, then surged by 65.75% to -$798000.0 in 2024, then fell by 20.55% to -$962000.0 in 2025.
  • Its last three reported values are -$962000.0 in Q1 2025, -$798000.0 for Q1 2024, and -$2.3 million during Q2 2023.